Sasaki-Higashimoto I, Fujishima F, Ishida H, Taniyama Y, Ozawa Y, Nakamura T
Pathol Int. 2025; 75(2):82-91.
PMID: 39760468
PMC: 11848974.
DOI: 10.1111/pin.13505.
Liu C, Ye L, Peng T, Chen L, Zhang Y, Zhou Y
Surg Endosc. 2024; 38(10):5575-5583.
PMID: 39090202
DOI: 10.1007/s00464-024-11124-y.
Selvaraj F, Joseph A, Pillai V, Ramani P, Pazhani J, Mony V
J Oral Maxillofac Pathol. 2024; 27(4):642-648.
PMID: 38304506
PMC: 10829472.
DOI: 10.4103/jomfp.jomfp_410_23.
El Yaagoubi S, Zaryouhi M, Benmaamar S, Agy F, Tahiri El Ousrouti L, Hammas N
Clin Pathol. 2023; 16:2632010X231184329.
PMID: 37426068
PMC: 10326459.
DOI: 10.1177/2632010X231184329.
Kato Y, Ito T, Yamamoto K, Furukawa A, Shintaku H, Yamamoto K
Virchows Arch. 2023; 483(5):645-653.
PMID: 37341813
DOI: 10.1007/s00428-023-03582-x.
Association between the expression levels of ADAMTS16 and BMP2 and tumor budding in hepatocellular carcinoma.
Jiang D, Xu S, Zhang C, Hu C, Li L, Zhang M
Oncol Lett. 2023; 25(6):256.
PMID: 37205917
PMC: 10189853.
DOI: 10.3892/ol.2023.13842.
Correlation of Tumor Budding With Known Clinicopathological, Histomorphological and Hormonal Receptor Status in Patients With Invasive Breast Carcinoma.
Rathod G, Desai K, Shrivastava A, Maru A
Cureus. 2022; 14(9):e29637.
PMID: 36320968
PMC: 9606632.
DOI: 10.7759/cureus.29637.
Organoid culture to study epithelial cell differentiation and barrier formation in the colon: bridging the gap between monolayer cell culture and human subject research.
Varani J, McClintock S, Aslam M
In Vitro Cell Dev Biol Anim. 2021; 57(2):174-190.
PMID: 33403624
PMC: 8720467.
DOI: 10.1007/s11626-020-00534-6.
The prognostic influence of tumour budding in Western patients with stage II colorectal cancer.
Cangucu A, Valerio E, Peixoto R, Felismino T, de Mello C, Neotti T
Ecancermedicalscience. 2020; 14:1130.
PMID: 33209121
PMC: 7652424.
DOI: 10.3332/ecancer.2020.1130.
Evaluation of Tumor Budding in Predicting Survival for Gastric Carcinoma Patients in Vietnam.
Dao T, Nguyen C, Nguyen Q, Vu H, Phung H, Bui O
Cancer Control. 2020; 27(1):1073274820968883.
PMID: 33136444
PMC: 7791444.
DOI: 10.1177/1073274820968883.
Tumour budding in solid cancers.
Lugli A, Zlobec I, Berger M, Kirsch R, Nagtegaal I
Nat Rev Clin Oncol. 2020; 18(2):101-115.
PMID: 32901132
DOI: 10.1038/s41571-020-0422-y.
Prognostic Role of Tumor Budding in Carcinoma Tongue: A Systemic Review and Meta-Analysis.
Karjol U, Jonnada P, Annavarjula V, Cherukuru S, Chandranath A, Anwar A
Cureus. 2020; 12(7):e9316.
PMID: 32714712
PMC: 7377011.
DOI: 10.7759/cureus.9316.
Infiltrative tumour growth pattern correlates with poor outcome in oesophageal cancer.
Anciaux M, Demetter P, de Wind R, Gomez Galdon M, Vande Velde S, Lens G
BMJ Open Gastroenterol. 2020; 7(1).
PMID: 32675198
PMC: 7368551.
DOI: 10.1136/bmjgast-2020-000431.
Tumour budding and its clinical implications in gastrointestinal cancers.
Zlobec I, Berger M, Lugli A
Br J Cancer. 2020; 123(5):700-708.
PMID: 32601463
PMC: 7462864.
DOI: 10.1038/s41416-020-0954-z.
Three-dimensional analysis of extrahepatic cholangiocarcinoma and tumor budding.
Yoshizawa T, Hong S, Jung D, Noe M, Kiemen A, Wu P
J Pathol. 2020; 251(4):400-410.
PMID: 32476131
PMC: 9920311.
DOI: 10.1002/path.5474.
Post-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinoma.
Jesinghaus M, Boxberg M, Wilhelm D, Munch S, Dapper H, Quante M
Br J Cancer. 2019; 121(12):1050-1057.
PMID: 31690830
PMC: 6964693.
DOI: 10.1038/s41416-019-0623-2.
Prognostic and pathological impact of tumor budding in gastric cancer: A systematic review and meta-analysis.
Guo Y, Zhang Z, Zhao G, Zhao E
World J Gastrointest Oncol. 2019; 11(10):898-908.
PMID: 31662828
PMC: 6815922.
DOI: 10.4251/wjgo.v11.i10.898.
Immunohistochemical analysis of tumor budding as predictor of lymph node metastasis from superficial esophageal squamous cell carcinoma.
Fuchinoue K, Nemoto T, Shimada H, Tochigi N, Igarashi Y, Yajima S
Esophagus. 2019; 17(2):168-174.
PMID: 31595396
DOI: 10.1007/s10388-019-00698-5.
CD44v9 is associated with epithelial-mesenchymal transition and poor outcomes in esophageal squamous cell carcinoma.
Taniguchi D, Saeki H, Nakashima Y, Kudou K, Nakanishi R, Kubo N
Cancer Med. 2018; 7(12):6258-6268.
PMID: 30474922
PMC: 6308082.
DOI: 10.1002/cam4.1874.
Tumour budding in rectal cancer. A comprehensive review.
Lino-Silva L, Salcedo-Hernandez R, Gamboa-Dominguez A
Contemp Oncol (Pozn). 2018; 22(2):61-74.
PMID: 30150882
PMC: 6103233.
DOI: 10.5114/wo.2018.77043.